Literature DB >> 978665

Acute leukemia in rheumatoid arthritis treated with cytotoxic agents.

A M Seidenfeld, H A Smythe, M A Ogryzlo, M B Urowitz, D A Dotten.   

Abstract

Acute leukemia is described in two patients treated with cytotoxic agents for a destructive, seropositive rheumatoid arthritis. Both patients had received longterm azathioprine therapy. In addition, one patient had been treated with cyclophosphamide, the other with melphalan. Chromosomal abnormalities were noted in both patients. Studies in one patient included colony forming units, ferrokinetics, electron microscopy of bone marrow, and autopsy examination. All reports of acute leukemia associated with cytostatic drugs in the literature to date are reviewed and the possible mechanisms discussed. It is suggested that patients with rheumatoid arthritis treated with azathioprine and alkylating agents may have an increased risk of developing a therapy-related acute leukemia.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 978665

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  9 in total

1.  High-dose short-term chlorambucil for intractable sympathetic ophthalmia and Behçet's disease.

Authors:  H H Tessler; T Jennings
Journal:  Br J Ophthalmol       Date:  1990-06       Impact factor: 4.638

2.  The occurrence of malignancies in patients with rheumatoid arthritis treated with cyclophosphamide: a controlled retrospective follow-up.

Authors:  J A Baltus; J W Boersma; A P Hartman; J P Vandenbroucke
Journal:  Ann Rheum Dis       Date:  1983-08       Impact factor: 19.103

3.  Therapeutic workshop on modifying the disease process in rheumatoid arthritis: immunosuppression in perspective.

Authors: 
Journal:  Ann Rheum Dis       Date:  1982       Impact factor: 19.103

Review 4.  Antirheumatic drugs: clinical pharmacology and therapeutic use.

Authors:  G L Craig; W W Buchanan
Journal:  Drugs       Date:  1980-12       Impact factor: 9.546

5.  Progressive rheumatoid arthritis: how far should we go with medical therapy?

Authors:  T P Anastassiades; I L Dwosh; P M Ford
Journal:  Can Med Assoc J       Date:  1980-06-07       Impact factor: 8.262

Review 6.  Remission-inducing drugs in rheumatoid arthritis.

Authors:  T P Anastassiades
Journal:  Can Med Assoc J       Date:  1980-02-23       Impact factor: 8.262

7.  Cause of death in patients with rheumatoid arthritis with particular reference to azathioprine.

Authors:  P Lewis; B L Hazleman; R Hanka; S Roberts
Journal:  Ann Rheum Dis       Date:  1980-10       Impact factor: 19.103

8.  [Acute leukemia after kidney allotransplantation (author's transl)].

Authors:  D Frei; U Binswanger; J Fehr; J Briner; C Sauter; F Largiadèr
Journal:  Blut       Date:  1980-05

Review 9.  Chemically induced leukemia in humans.

Authors:  R H Adamson; S M Seiber
Journal:  Environ Health Perspect       Date:  1981-06       Impact factor: 9.031

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.